Consideration of confounders, accuracy of diagnosis, and disease severity in assessing the risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis beginning interleukin‐7 inhibitor treatment: comment on the article by Penso et al

Cheng‐Ruei YangAmy KerPei‐En KaoJames Cheng‐Chung Wei2026-01-302026-01-302022-02-0910.1002/art.41960https://scholars.csmu.edu.tw/handle/123456789/4353[SDGs]SDG3Consideration of confounders, accuracy of diagnosis, and disease severity in assessing the risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis beginning interleukin‐7 inhibitor treatment: comment on the article by Penso et aljournal-article